title: Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry. For the BARI Investigators.
abstract: BACKGROUND
  The impact of percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass grafting (CABG) on long-term mortality rates in the presence of various demographic, clinical, and angiographic factors is uncertain in the population of patients suitable for both procedures.
  
  
  RESULTS
  In the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial and registry, 3610 patients who were eligible to receive PTCA and CABG were revascularized between 1989 and 1992. Multivariate Cox models were used to identify factors associated with 5-year mortality and cardiac mortality, with particular attention to factors that interact with treatment. Diabetic patients receiving insulin had higher mortality and cardiac mortality rates with PTCA compared with CABG (relative risk [RR] 1.78 and 2.63, respectively, P<0.001), and patients with ST elevation had higher cardiac mortality rates with CABG than with PTCA (RR 4.08, P<0.001). Factors most strongly associated with high overall mortality rates were insulin-treated diabetes, congestive heart failure, kidney failure, and older age. Black race was also associated with higher mortality rates (RR 1.49, P=0.019).
  
  
  CONCLUSIONS
  A set of variables was identified that could be used to help select a revascularization procedure and to evaluate risk of long-term mortality in the population of patients considering revascularization.
authors.affiliation: University of Pittsburgh, PA 15261, USA. brooks@edc.gsph.pitt.edu
authors.forename: M M
authors.initials: MM
authors.lastname: Brooks
authors.forename: R H
authors.initials: RH
authors.lastname: Jones
authors.forename: R G
authors.initials: RG
authors.lastname: Bach
authors.forename: B R
authors.initials: BR
authors.lastname: Chaitman
authors.forename: M J
authors.initials: MJ
authors.lastname: Kern
authors.forename: T A
authors.initials: TA
authors.lastname: Orszulak
authors.forename: D
authors.initials: D
authors.lastname: Follmann
authors.forename: G
authors.initials: G
authors.lastname: Sopko
authors.forename: E H
authors.initials: EH
authors.lastname: Blackstone
authors.forename: R M
authors.initials: RM
authors.lastname: Califf
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000401:mortality*; D002423:Cause of Death; D001026:Coronary Artery Bypass / Q000401:mortality*; D003924:Diabetes Mellitus, Type 2 / Q000401:mortality; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D017202:Myocardial Ischemia / Q000401:mortality / Q000601:surgery / Q000628:therapy; D011237:Predictive Value of Tests; D012042:Registries; D016019:Survival Analysis